The Lanka Hospitals Corporation PLC (COSE:LHCL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
COSE:LHCL.N0000 Income Statement
Financials in millions LKR. Fiscal year is January - December.
Millions LKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15,128 | 14,474 | 13,650 | 12,419 | 10,698 | 10,034 | |
Revenue Growth | 10.39% | 6.04% | 9.92% | 16.09% | 6.62% | 47.47% |
Cost of Revenue | 8,265 | 8,063 | 7,700 | 7,210 | 6,260 | 5,270 |
Gross Profit | 6,862 | 6,411 | 5,951 | 5,209 | 4,438 | 4,764 |
Selling, General & Admin | 3,574 | 3,295 | 3,073 | 2,824 | 2,389 | 2,290 |
Other Operating Expenses | 1,249 | 1,153 | 1,140 | 1,187 | 845.68 | 623.43 |
Operating Expenses | 4,823 | 4,448 | 4,214 | 4,011 | 3,235 | 2,914 |
Operating Income | 2,039 | 1,963 | 1,737 | 1,198 | 1,203 | 1,850 |
Interest Expense | -55.74 | -54.54 | -57.94 | -33.03 | -30.38 | -32.6 |
Interest & Investment Income | 709.25 | 645.62 | 678.05 | 1,258 | 927.52 | 252.32 |
Currency Exchange Gain (Loss) | 561.57 | 274.75 | -433.88 | -518.04 | 1,955 | 153.95 |
Other Non Operating Income (Expenses) | 0 | 0 | 0 | -0 | 0 | 0 |
EBT Excluding Unusual Items | 3,254 | 2,829 | 1,923 | 1,904 | 4,055 | 2,224 |
Gain (Loss) on Sale of Assets | 1.27 | 1.27 | -27.73 | 5.83 | 5.8 | 9.04 |
Pretax Income | 3,255 | 2,830 | 1,895 | 1,910 | 4,061 | 2,233 |
Income Tax Expense | 874.89 | 885.55 | 555.89 | 564.76 | 814.34 | 21.12 |
Net Income | 2,381 | 1,944 | 1,339 | 1,345 | 3,247 | 2,212 |
Net Income to Common | 2,381 | 1,944 | 1,339 | 1,345 | 3,247 | 2,212 |
Net Income Growth | 56.46% | 45.16% | -0.43% | -58.57% | 46.82% | 474.43% |
Shares Outstanding (Basic) | 224 | 224 | 224 | 224 | 224 | 224 |
Shares Outstanding (Diluted) | 224 | 224 | 224 | 224 | 224 | 224 |
Shares Change | 0.11% | - | - | - | - | - |
EPS (Basic) | 10.64 | 8.69 | 5.99 | 6.01 | 14.51 | 9.88 |
EPS (Diluted) | 10.64 | 8.69 | 5.99 | 6.01 | 14.51 | 9.88 |
EPS Growth | 56.28% | 45.15% | -0.39% | -58.58% | 46.86% | 474.16% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 877.8 | 1,691 | 598.16 | 663.43 | 343.3 | 1,710 |
Free Cash Flow Per Share | 3.92 | 7.56 | 2.67 | 2.96 | 1.53 | 7.64 |
Dividend Per Share | 1.000 | 3.000 | 1.500 | - | 3.500 | 2.750 |
Dividend Growth | -71.43% | 100.00% | - | - | 27.27% | - |
Gross Margin | 45.36% | 44.29% | 43.59% | 41.95% | 41.48% | 47.48% |
Operating Margin | 13.48% | 13.56% | 12.72% | 9.64% | 11.25% | 18.44% |
Profit Margin | 15.74% | 13.43% | 9.81% | 10.83% | 30.35% | 22.04% |
Free Cash Flow Margin | 5.80% | 11.69% | 4.38% | 5.34% | 3.21% | 17.04% |
EBITDA | 2,757 | 2,697 | 2,365 | 1,775 | 1,664 | 2,308 |
EBITDA Margin | 18.23% | 18.64% | 17.33% | 14.29% | 15.55% | 23.00% |
D&A For EBITDA | 718.21 | 734.52 | 628.44 | 577.32 | 460.63 | 458.1 |
EBIT | 2,039 | 1,963 | 1,737 | 1,198 | 1,203 | 1,850 |
EBIT Margin | 13.48% | 13.56% | 12.72% | 9.64% | 11.25% | 18.44% |
Effective Tax Rate | 26.88% | 31.29% | 29.33% | 29.57% | 20.05% | 0.95% |